Korean J Dermatol.
1996 Dec;34(6):980-983.
The Use of Hydroxychloroquine in Patients with Pemphigus Erythematosus
- Affiliations
-
- 1Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea.
Abstract
- Pemphigus erythematosus (PE) is a superficial type of pemphigus, which can be aggravated by sunlight (espicially UV light). Because of the known side effects of corticosteroids, we evaluated the efficacy of hydroxychloroquine as a corticosteroid-sparing agent and/or the effect of a single-drug regimen in two patients with PE with photosensitivity. We obtained a good therapeutic response with hydroxychloroquine in these two patients with PE. This drug could be used in selected patients with pemphigus who are prednisolone/ immunosuppressive-resistant or who have certain degrees of photosensitivity.